Saber Magdy M, Zeeneldin Ahmed A, Samra Mohamed A, Farag Sarah A
Department of Medical Oncology, National Cancer Institute, Cairo University, Egypt.
J Egypt Natl Canc Inst. 2013 Jun;25(2):95-101. doi: 10.1016/j.jnci.2013.03.006. Epub 2013 Apr 28.
Gastrointestinal lymphoma (GIL) is the most common extranodal form of non-Hodgkin's lymphoma (NHL) with geographical and age variation of its various subtypes.
To study GIL in Gharbiah, Egypt and to recognize the treatments employed and their outcomes including survival.
This is a retrospective study. Between 2000 and 2002, 40 adult patients with GIL were identified in the Gharbiah population based cancer registry (GPBCR); 26 cases of whom were treated at Tanta Cancer Center (TCC).
GIL in Gharbiah, Egypt represented 6.2% of all GIT cancers. The median age was 47 years with slight male predominance. The commonest primary site was the stomach followed by the colon/rectum then the small intestine (67.5%, 25% and 7.5%, respectively). The commonest histological subtypes were the diffuse large B-cell (41.5%) followed by marginal zone B-cell (39%). The commonest symptoms were abdominal pains followed by vomiting. Only 18% of GILs were surgically resected. Most patients (77%) received chemotherapy with a 60% complete response (CR) rate. Once in CR, relapses are occasional. The median overall survival (OS) and progression free survival (PFS) were 31 and 14 months (95% CI, 13.2-48.7 and 6.4-21.6 months, respectively). Gastric primary site and diffuse large B cell subtype carry a non-significant worse OS and PFS than those of other sites and subtypes.
GILs in Gharbiah, Egypt are characterized by predominance of male gender, gastric site and marginal zone histology. Survival is worse for gastric and diffuse large B-cell GILs compared to other sites and histologies.
胃肠道淋巴瘤(GIL)是最常见的非霍奇金淋巴瘤(NHL)结外形式,其各亚型存在地域和年龄差异。
研究埃及盖尔比亚省的胃肠道淋巴瘤,并了解所采用的治疗方法及其包括生存情况在内的结果。
这是一项回顾性研究。2000年至2002年期间,在盖尔比亚省人群癌症登记处(GPBCR)中确定了40例成年胃肠道淋巴瘤患者;其中26例在坦塔癌症中心(TCC)接受治疗。
埃及盖尔比亚省的胃肠道淋巴瘤占所有胃肠道癌症的6.2%。中位年龄为47岁,男性略占优势。最常见的原发部位是胃,其次是结肠/直肠,然后是小肠(分别为67.5%、25%和7.5%)。最常见的组织学亚型是弥漫性大B细胞型(41.5%),其次是边缘区B细胞型(39%)。最常见的症状是腹痛,其次是呕吐。只有18%的胃肠道淋巴瘤患者接受了手术切除。大多数患者(77%)接受了化疗,完全缓解(CR)率为60%。一旦达到完全缓解,复发情况较为少见。中位总生存期(OS)和无进展生存期(PFS)分别为31个月和14个月(95%CI分别为13.2 - 48.7个月和6.4 - 21.6个月)。胃原发部位和弥漫性大B细胞亚型的总生存期和无进展生存期比其他部位和亚型略差,但差异无统计学意义。
埃及盖尔比亚省的胃肠道淋巴瘤具有男性占优势、胃部位和边缘区组织学特征。与其他部位和组织学类型相比,胃和弥漫性大B细胞型胃肠道淋巴瘤的生存情况较差。